CAS 1357072-61-7

Formula: C17H14N8S

InChI: InChI=1S/C17H14N8S/c1-23-10-12(8-18-23)15-5-6-16-19-20-17(25(16)22-15)26-13-3-4-14-11(7-13)9-24(2)21-14/h3-10H,1-2H3

InChI key: JYXHZDNTBJUJNH-UHFFFAOYSA-N

SMILES: CN1C=C(C=N1)C2=NN3C(=NN=C3SC4=CC5=CN(N=C5C=C4)C)C=C2

c-Met inhibitor 1

CAS: 1357072-61-7

c-Met inhibitor 1

Formula: C₁₇H₁₄N₈S

Purity: ≥98%

Molecular weight: 362.41

Ref: 54-BUP02416

c-Met inhibitor 1

CAS: 1357072-61-7

c-Met inhibitor 1 is a c-Met receptor signaling pathway inhibitor, used for the treatment of cancer including glioblastoma, gastric, and pancreatic cancer.

Formula: C₁₇H₁₄N₈S

Purity: 98.77%

Color and Shape: Solid

Molecular weight: 362.412

Ref: TM-T10655

c-Met inhibitor 1

CAS: 1357072-61-7

Formula: C₁₇H₁₄N₈S

Purity: 98%

Molecular weight: 362.4117

Ref: IN-DA009CAK

c-Met inhibitor 1

CAS: 1357072-61-7

6-(1-Methyl-1H-pyrazol-4-yl)-3-((2-methyl-2H-indazol-5-yl)thio)-[1,2,4]triazolo[4,3-b]pyridazine

Formula: C₁₇H₁₄N₈S

Purity: 98%

Molecular weight: 362.41

Ref: IN-DG329201

6-(1-METHYL-1H-PYRAZOL-4-YL)-3-((2-METHYL-2H-INDAZOL-5-YL)THIO)-[1,2,4]TRIAZOLO[4,3-B]PYRIDAZINE

CAS: 1357072-61-7

Formula: C₁₇H₁₄N₈S

Purity: 99.26%

Molecular weight: 362.42

Ref: 10-F390260